Anitrazafen
 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| Chemical and physical data | |
| Formula | C18H17N3O2 |
| Molar mass | 307.35 g/mol |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Anitrazifen is a drug displaying COX-2 inhibitor activity.
| Pyrazolones / Pyrazolidines | |
|---|---|
| Salicylates | |
| Acetic acid derivatives and related substances | |
| Oxicams | |
| Propionic acid derivatives (profens) |
|
| N-Arylanthranilic acids (fenamates) | |
| Coxibs | |
| Other | |
Items listed in bold indicate initially developed compounds of specific groups. #WHO-EM †Withdrawn drugs. ‡Veterinary use medications. | |
| Receptor (ligands) |
| ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Enzyme (inhibitors) |
| ||||||||||||||||||||||||||
| Others | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.